# Hemu (China) Bioengineering Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hemu-china-bioengineering-co

- Industry: Medical Devices & Equipment
- Headquarters: Weihai, China
- Website: www.hemochina.com
- Total disclosed funding: $14M
- Latest round: Series B (Oct 20, 2020)
- Investors on record: 3

## About

Founded in 2016 and based in Weihai City, China, Hemu (China) Bioengineering Co.,Ltd.  is a company that develops and manufactures medical devices focused on interventional treatment of vascular diseases, and provides overall neuro-intervention solutions for ischemic stroke, hemorrhagic stroke, and intracranial vascular stenosis.

## Funding rounds

- Series B, Oct 20, 2020, $14M — Legend Capital, Hillhouse Investment, 3H Health Investment

## Investors

- Legend Capital — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series B
- 3H Health Investment (https://capitalatlas.ai/funds/3h-health-investment) — Series B